CIK: 1230484 - Address: C/O Outlook Therapeutics, Inc., 485 Route 1 South, Bldg F, Suite 320, Iselin, NJ 08830
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret111-10-294237
S%wins10010010000050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/20/21 19:54
4/20/21
OTLKOutlook Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJDOCEO,P,CFP181.8301011219D
10/15/19 17:08
9/18/19
OTLKOutlook Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJDOCEO,P,CFS.a-21.700-1-139D
9/23/19 17:09
9/18/19
OTLKOutlook Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJDOCEO,P,CFS-21.700-1-281D
2/8/19 20:14
2/7/19
OTLKOutlook Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJDOCEO,P,CFP220.89520254482D
9/18/18 16:56
9/18/18
ONSOncobiologics, Inc.DEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJDOCEO,P,CFS-90.87200-10-1557D
12/26/17 17:04
12/22/17
ONSOncobiologics, Inc.DEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJOCFO,SecrS-301.130-26-2867D
3/3/10 18:25
3/3/10
PRXPar Pharmaceutical Companies, Inc.DEHealthDrugPharmaceutical PreparationsKenyon Lawrence ANJOEVP,CFOM.d28013.06122121D42111235-75-10-10-29423
3/3/10 18:25
3/3/10
PRXPar Pharmaceutical Companies, Inc.DEHealthDrugPharmaceutical PreparationsKenyon Lawrence ANJOEVP,CFOS.d-54025.2012-21-5121D42111235-75-10-10-29423
4/12/07 17:07
4/11/07
ACELAlfacell CorpDEHealthBioPrdBiological Products, (No DiagKenyon Lawrence ANJOEVP,CFO,P532.14025New25D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact